NIH-funded research R01 grant

Genetic factors that influence Duchenne Muscular Dystrophy progression

Official title: Genetic modifiers of Duchenne Muscular Dystrophy

Funded at Research Inst Nationwide Children's Hosp · NIH-11377465 · Data updated 2026-11-12

A study to find genes that change how severe Duchenne muscular dystrophy is in boys and young men, using patient data and DNA samples.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionResearch Inst Nationwide Children's Hosp
NIH-funded
Lab location1 site (Columbus, United States)
Project startMay 15, 2014
Project endJuly 31, 2027
Funding year2026
Award (this year)$921,491
NIH project number5R01NS085238-10
Project IDNIH-11377465 on NIH RePORTER

Who could benefit from this research

Could help

Young men and boys with Duchenne muscular dystrophy or related dystrophinopathies who are represented in the UDP database.

Less likely to help

Patients whose disease is not influenced by the identified modifiers or who are not represented in the UDP dataset may see no direct benefit.

What this research studies

This project looks at genetic modifiers that may affect how quickly Duchenne Muscular Dystrophy progresses in skeletal muscles, the heart, and breathing. Researchers will analyze phenotypic data and archived DNA from the United Dystrophinopathy Project to identify genes linked to milder or more severe disease courses. They will update the UDP dataset and map traits related to disease progression using existing patient information to find potential modifier genes. The goal is to better understand why some patients fare differently and to inform future therapies. Results could guide personalized approaches to care and treatment decisions for individuals with DMD.

Why it matters

Potential benefit: Identifying modifier genes could lead to new targets for therapies and more personalized care plans for people with DMD.

How similar studies have gone: Prior work has shown that specific gene variants (like LTBP4) can influence disease progression in DMD, supporting the potential for new modifiers to be found.

Where this research is happening

  • Research Inst Nationwide Children's Hosp
    Columbus, United States
    Active

Researchers

  • Principal investigator: Flanigan, Kevin M — Research Inst Nationwide Children's Hosp
  • Study coordinator: Flanigan, Kevin M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.